Press Resease

Active Pharmaceutical Ingredients Market by API Synthesis (Biotech API, Synthetic Chemical API, and HPAPI), by Type of Manufacturing (Contract Manufacturing and In-House API Manufacturing), by Type of API (Synthetic API and Biological API), by Drug type (Into Branded Drugs, Generic Drugs and OTC Drugs), for Cardiology, Oncology, Anti-Inflammatory, Gastrointestinal and Other Application - Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021

Published Date: 02-Aug-2016 Category: Pharmaceutical Report Format : PDF Pages: 110 Report Code: ZMR-56 Status : Published

Global active pharmaceutical ingredient market to reach USD 213.84 billion by 2021 and is growing at a CAGR of 6.3% during 2016-2021

Description

The report covers forecast and analysis for the active pharmaceutical ingredient market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD Billion). The study includes drivers and restraints for the active pharmaceutical ingredient along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the active pharmaceutical ingredient market on a global level.

In order to give the users of this report a comprehensive view on the active pharmaceutical ingredient market, we have included a detailed segmentation of active pharmaceutical ingredient. To understand the competitive landscape in the market, an analysis of Porter’s Five Forces model for the active pharmaceutical ingredient market has also been included. The study encompasses a market attractiveness analysis, wherein type segments and application segments are benchmarked based on their market size, growth rate, and general attractiveness.

The study provides a decisive view on the active pharmaceutical ingredient market by segmenting the market based on API synthesis, biotech API, synthetic chemical API and HPAPI. All the segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021. The active pharmaceutical ingredient market’s manufacturing type segment includes contract manufacturing and in-house API manufacturing. The drug type segment includes branded drugs, generic drugs, and OTC drugs. The regional segmentation includes the current and forecast demand for North America, Europe, Asia-Pacific and Rest of the world. This segmentation includes demand for active pharmaceutical ingredient based on individual applications in all the regions.

The key players active in this market are Sun Pharmaceuticals Industries Limited, Novartis International AG, BASF SE, Pfizer, Inc., Aurobindo, Albemarle Corporation, and Boehringer Ingelheim among others.

The report segments the global active pharmaceutical ingredient market as

Active Pharmaceutical Ingredient Market: API Synthesis Segment Analysis

  • Biotech API
  • Synthetic Chemical API
  • HPAPI

Active Pharmaceutical Ingredient Market: Type of Manufacturing Segment Analysis

  • Contract Manufacturing
  • In-House API Manufacturing

Active Pharmaceutical Ingredient Market: Type of API Segment Analysis

  • Synthetic API
  • Biological API

Active Pharmaceutical Ingredient Market: Drug Type Segment Analysis

  • Branded Drugs
  • Generic Drugs
  • OTC Drugs

Active Pharmaceutical Ingredient Market: Therapeutic Application Segment Analysis

  • Cardiology
  • Oncology
  • Anti-Inflammatory
  • Gastrointestinal 
  • Other

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  • Chapter 2. Executive Summary
    • 2.1. Global Active pharmaceutical ingredient Market, 2015 - 2021, (USD Billion)
    • 2.2. Active pharmaceutical ingredient: Market snapshot
  • Chapter 3. Active pharmaceutical ingredient Market: Industry Analysis
    • 3.1. Active pharmaceutical ingredient: Market dynamics
    • 3.2. Market Drivers
      • 3.2.1. Increasing prevalence of chronic diseases
      • 3.2.2. Technological advancements in the API
      • 3.2.3. Patent expiration of major drugs that increased generic drug sales
      • 3.2.4. Government initiatives
    • 3.3. Restraints
      • 3.3.1. Stringent regulatory requirement
      • 3.3.2. Decline in global economics
    • 3.4. Opportunity
      • 3.4.1. Demand for active pharmaceutical ingredient for various diseases treatment
    • 3.5. Porter’s Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis by API synthesis segment
      • 3.6.2. Market attractiveness analysis by type of manufacturing segment
      • 3.6.3. Market attractiveness analysis by type of API segment
      • 3.6.4. Market attractiveness analysis by drug type segment
      • 3.6.5. Market attractiveness analysis by Application segment
      • 3.6.6. Market attractiveness analysis by region segment
  • Chapter 4. Global Active pharmaceutical ingredient Market: Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global active pharmaceutical ingredient market: company market share, 2015
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Product Launch
      • 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
      • 4.2.4. Research and Development, Product and Regional Expansion
    • 4.3. Price Trend Analysis
    • 4.4. Product Portfolio
    • 4.5. Patent Analysis (2011-2016)
      • 4.5.1. Patent Trend
      • 4.5.2. Patent Share by company
      • 4.5.3. By Region
  • Chapter 5. Global Active pharmaceutical ingredient Market: API Synthesis Type Overview
    • 5.1. Global active pharmaceutical ingredient market share, by API Synthesis type, 2015 and 2021
    • 5.2. Global active pharmaceutical ingredient market for biotech APItype, 2015 - 2021(USD Billion)
    • 5.3. Global active pharmaceutical ingredient market for synthetic chemical API, 2015 - 2021 (USD Billion)
    • 5.4. Global active pharmaceutical ingredient market for HPAPI type, 2015 - 2021 (USD Billion)
  • Chapter 6. Global active pharmaceutical ingredient Market: Type of Manufacturing Overview
    • 6.1. Global active pharmaceutical ingredient market share, by type of Manufacturing, 2015 and 2021
    • 6.2. Global active pharmaceutical ingredient market for contract manufacturing, 2015 - 2021(USD Billion)
    • 6.3. Global active pharmaceutical ingredient market for in-house API manufacturing, 2015 - 2021 (USD Billion)
  • Chapter 7. Global active pharmaceutical ingredient Market: Type of API Overview
    • 7.1. Global active pharmaceutical ingredient market share for type of API , 2015 and 2021
    • 7.2. Global active pharmaceutical ingredient market for synthetic API, 2015 - 2021(USD Billion)
    • 7.3. Global active pharmaceutical ingredient market for biological API, 2015 - 2021 (USD Billion)
  • Chapter 8. Global active pharmaceutical ingredient Market: Drug Type Overview
    • 8.1. Global active pharmaceutical ingredient market share for type of drug, 2015 and 2021
    • 8.2. Global active pharmaceutical ingredient market for branded drugs, 2015 - 2021(USD Billion)
    • 8.3. Global active pharmaceutical ingredient market for generic drugs, 2015 - 2021 (USD Billion)
    • 8.4. Global active pharmaceutical ingredient market for OTC drugs, 2015 - 2021 (USD Billion)
  • Chapter 9. Global active pharmaceutical ingredient Market: Application Overview
    • 9.1. Global active pharmaceutical ingredient market share for application , 2015 and 2021
    • 9.2. Global active pharmaceutical ingredient market for cardiology, 2015 - 2021(USD Billion)
    • 9.3. Global active pharmaceutical ingredient market for oncology, 2015 - 2021 (USD Billion)
    • 9.4. Global active pharmaceutical ingredient market for anti-inflammatory, 2015 - 2021 (USD Billion)
    • 9.5. Global active pharmaceutical ingredient market for gastrointestinal, 2015 - 2021 (USD Billion)
    • 9.6. Global active pharmaceutical ingredient market for others, 2015 - 2021 (USD Billion)
  • Chapter 10. Global active pharmaceutical ingredient Market: Regional Analysis
    • 10.1. Global active pharmaceutical ingredient market: Regional overview
      • 10.1.1. Global active pharmaceutical ingredient market share, by region, 2015 and 2021
    • 10.2. North America
      • 10.2.1. North America active pharmaceutical ingredient market revenue, by API Synthesis, 2015 – 2021 (USD Billion)
      • 10.2.2. North America active pharmaceutical ingredient market revenue, type of Manufacturing, 2015 – 2021 (USD Billion)
      • 10.2.3. North America active pharmaceutical ingredient market revenue, by type of API, 2015 – 2021 (USD Billion)
      • 10.2.4. North America active pharmaceutical ingredient market revenue, by drug type, 2015 – 2021 (USD Billion)
      • 10.2.5. North America active pharmaceutical ingredient market revenue, by application, 2015 – 2021 (USD Billion)
      • 10.2.6. U.S.
        • 10.2.6.1. U.S active pharmaceutical ingredient market revenue, by API Synthesis, 2015 – 2021 (USD Billion)
        • 10.2.6.2. U.S active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 – 2021 (USD Billion)
        • 10.2.6.3. U.S active pharmaceutical ingredient market revenue, by type of API, 2015 – 2021 (USD Billion)
        • 10.2.6.4. U.S active pharmaceutical ingredient market revenue, by drug type, 2015 – 2021 (USD Billion)
        • 10.2.6.5. U.S active pharmaceutical ingredient market revenue, by application, 2015 – 2021 (USD Billion)
    • 10.3. Europe
      • 10.3.1. Europe active pharmaceutical ingredient market revenue, by API Synthesis, 2015 – 2021 (USD Billion)
      • 10.3.2. Europe active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 – 2021 (USD Billion)
      • 10.3.3. Europe active pharmaceutical ingredient market revenue, by type of API , 2015 – 2021 (USD Billion)
      • 10.3.4. Europe active pharmaceutical ingredient market revenue, by drug type , 2015 – 2021 (USD Billion)
      • 10.3.5. Europe active pharmaceutical ingredient market revenue, by application , 2015 – 2021 (USD Billion)
      • 10.3.6. UK
        • 10.3.6.1. UK active pharmaceutical ingredient market revenue, by API Synthesis, 2015 – 2021 (USD Billion)
        • 10.3.6.2. UK active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 – 2021 (USD Billion)
        • 10.3.6.3. UK active pharmaceutical ingredient market revenue, by type of API, 2015 – 2021 (USD Billion)
        • 10.3.6.4. UK active pharmaceutical ingredient market revenue, by drug type, 2015 – 2021 (USD Billion)
        • 10.3.6.5. UK active pharmaceutical ingredient market revenue, by application, 2015 – 2021 (USD Billion)
      • 10.3.7. France
        • 10.3.7.1. France active pharmaceutical ingredient market revenue, by API Synthesis, 2015 – 2021 (USD Billion)
        • 10.3.7.2. France active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 – 2021 (USD Billion)
        • 10.3.7.3. France active pharmaceutical ingredient market revenue, by type of API 2015 – 2021 (USD Billion)
        • 10.3.7.4. France active pharmaceutical ingredient market revenue, by drug type 2015 – 2021 (USD Billion)
        • 10.3.7.5. France active pharmaceutical ingredient market revenue, by application 2015 – 2021 (USD Billion)
      • 10.3.8. Germany
        • 10.3.8.1. Germany active pharmaceutical ingredient market revenue, by API Synthesis, 2015 – 2021 (USD Billion)
        • 10.3.8.2. Germany active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 – 2021 (USD Billion)
        • 10.3.8.3. Germany active pharmaceutical ingredient market revenue, by type of API, 2015 – 2021 (USD Billion)
        • 10.3.8.4. Germany active pharmaceutical ingredient market revenue, by drug type, 2015 – 2021 (USD Billion
        • 10.3.8.5. Germany active pharmaceutical ingredient market revenue, by application, 2015 – 2021 (USD Billion
    • 10.4. Asia Pacific
      • 10.4.1. Asia Pacific active pharmaceutical ingredient market revenue, by API Synthesis, 2015 – 2021 (USD Billion)
      • 10.4.2. Asia Pacific active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 – 2021 (USD Billion)
      • 10.4.3. Asia Pacific active pharmaceutical ingredient market revenue, by type of API , 2015 – 5 – 2021 (USD Billion)
      • 10.4.4. Asia Pacific active pharmaceutical ingredient market revenue, by drug type , 2015 – 5 – 2021 (USD Billion)
      • 10.4.5. Asia Pacific active pharmaceutical ingredient market revenue, by application , 2015 – 5 – 2021 (USD Billion)
      • 10.4.6. China
        • 10.4.6.1. China active pharmaceutical ingredient market revenue, by API Synthesis, 2015 – 2021 (USD Billion)
        • 10.4.6.2. China active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 – 2021 (USD Billion)
        • 10.4.6.3. China active pharmaceutical ingredient market revenue, by type of API, 2015 – 2021 (USD Billion)
        • 10.4.6.4. China active pharmaceutical ingredient market revenue, by drug type, 2015 – 2021 (USD Billion)
        • 10.4.6.5. China active pharmaceutical ingredient market revenue, by application, 2015 – 2021 (USD Billion)
      • 10.4.7. India
        • 10.4.7.1. India active pharmaceutical ingredient market revenue, by API Synthesis, 2015 – 2021 (USD Billion)
        • 10.4.7.2. India active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 – 2021 (USD Billion)
        • 10.4.7.3. India active pharmaceutical ingredient market revenue, by type of API, 2015 – 2021 (USD Billion)
        • 10.4.7.4. India active pharmaceutical ingredient market revenue, by drug type, 2015 – 2021 (USD Billion)
        • 10.4.7.5. India active pharmaceutical ingredient market revenue, by application, 2015 – 2021 (USD Billion)
    • 10.5. Latin America
      • 10.5.1. Latin America active pharmaceutical ingredient market revenue, by API Synthesis, 2015 – 2021 (USD Billion)
      • 10.5.2. Latin America active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 – 2021 (USD Billion)
      • 10.5.3. Latin America active pharmaceutical ingredient market revenue, by type of API, 2015 – 2021 (USD Billion)
      • 10.5.4. Latin America active pharmaceutical ingredient market revenue, by drug type, 2015 – 2021 (USD Billion)
      • 10.5.5. Latin America active pharmaceutical ingredient market revenue, by application, 2015 – 2021 (USD Billion)
      • 10.5.6. Brazil
        • 10.5.6.1. Brazil active pharmaceutical ingredient market revenue, by API Synthesis, 2015 – 2021 (USD Billion)
        • 10.5.6.2. Brazil active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 – 2021 (USD Billion)
        • 10.5.6.3. Brazil active pharmaceutical ingredient market revenue, by type of API, 2015 – 2021 (USD Billion)
        • 10.5.6.4. Brazil active pharmaceutical ingredient market revenue, by drug type, 2015 – 2021 (USD Billion)
        • 10.5.6.5. Brazil active pharmaceutical ingredient market revenue, by application, 2015 – 2021 (USD Billion)
    • 10.6. Middle East & Africa
      • 10.6.1. Middle East & Africa active pharmaceutical ingredient market revenue, by API Synthesis, 2015 – 2021 (USD Billion)
      • 10.6.2. Middle East & Africa active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 – 2021 (USD Billion)
      • 10.6.3. Middle East & Africa active pharmaceutical ingredient market revenue, by type of API, 2015 – 2021 (USD Billion)
      • 10.6.4. Middle East & Africa active pharmaceutical ingredient market revenue, by drug type, 2015 – 2021 (USD Billion)
      • 10.6.5. Middle East & Africa active pharmaceutical ingredient market revenue, by application, 2015 – 2021 (USD Billion)
  • Chapter 11. Company Profiles
    • 11.1. Novartis International AG
      • 11.1.1. Overview
      • 11.1.2. Financials
      • 11.1.3. Product portfolio
      • 11.1.4. Business strategy
      • 11.1.5. Recent developments
    • 11.2. Pfizer
      • 11.2.1. Overview
      • 11.2.2. Financials
      • 11.2.3. Product portfolio
      • 11.2.4. Business strategy
      • 11.2.5. Recent developments
    • 11.3. Aurobindo
      • 11.3.1. Overview
      • 11.3.2. Financials
      • 11.3.3. Product portfolio
      • 11.3.4. Business strategy
      • 11.3.5. Recent developments
    • 11.4. Albemarle Corporation
      • 11.4.1. Overview
      • 11.4.2. Financials
      • 11.4.3. Product portfolio
      • 11.4.4. Business strategy
      • 11.4.5. Recent developments
    • 11.5. Boehringer Ingelheim
      • 11.5.1. Overview
      • 11.5.2. Financials
      • 11.5.3. Product portfolio
      • 11.5.4. Business strategy
      • 11.5.5. Recent developments
    • 11.6. BASF SE
      • 11.6.1. Overview
      • 11.6.2. Financials
      • 11.6.3. Product portfolio
      • 11.6.4. Business strategy
      • 11.6.5. Recent developments
  • Chapter 12. Patents
    • 12.1. U.S. (US Patents)
    • 12.2. Europe (EP documents)
    • 12.3. Japan (Abstracts of Japan)
    • 12.4. Global (WIPO (PCT))

Methodology

This report is based on in-depth qualitative and quantitative analyses of the global Active Pharmaceutical Ingredients market. Zion Research has collected and analyzed key data belong to the global Active Pharmaceutical Ingredients market using a variety of methods. Quantitative analysis has been done following various projection and sampling techniques.

The qualitative analysis involved primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes were validated through experts' opinions. The market dynamics have been determined after conducting a detailed study of the micro and macroeconomic indicators of the market.

Various parameters have been taken into account while estimating market size. The revenue generated by the leading industry participants in from the sales of Active Pharmaceutical Ingredients across the world has been calculated through primary and secondary research.

Zion Research employs the combination of secondary research followed by extensive primary research. Under secondary research, we refer to prominent paid as well as open access data sources including product literature, company annual reports, government publications, press releases, industry association’s magazines and other relevant sources for data collection. Other prominent secondary sources include STATISTA, trade journals, trade associations, statistical data from government websites, etc. 

For this study, Zion Research has conducted all-encompassing primary research with key industry participants to collect first had data. Moreover, in-depth interviews with key opinion leaders also assisted in validation of findings from secondary research and to understand key trends in the Active Pharmaceutical Ingredients industry. Primary research makes up the major source of data collection and validation.   

Primary Research

We conduct primary interviews with industry participants and commentators on an ongoing basis to validate data and analysis. A typical research interview fulfills the following functions:

  • Provides firsthand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
  • Helps in validating and strengthening the secondary research findings
  • Further, develops the analysis team’s expertise and market understanding
  • Primary research involves e-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies

Participants who typically participate in such a process include, but are not limited to:

  • Industry participants: CEOs, VPs, marketing/product managers, market intelligence managers and national sales managers
  • Purchasing managers, technical personnel, distributors and resellers
  • Outside experts: Investment bankers, valuation experts and research analysts specializing in specific markets

Key opinion leaders specializing in different areas corresponding to different industry verticals

Secondary Research

Secondary research sources that are typically referred to include, but are not limited to:

  • Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
  • IDC and other relevant magazines
  • Internal and external proprietary databases, and relevant patent and regulatory databases
  • National government documents, statistical databases and market reports

News articles, press releases and webcasts specific to companies operating in the market

Following a comprehensive secondary and primary research and insights thus gathered, analysts at Zion Research have provided an in-depth analysis of various aspects of the Active Pharmaceutical Ingredients market.

Models

Where no hard data is available, we use models and estimates to produce comprehensive data sets. A rigorous methodology is adopted, wherein the available hard data is cross-referenced with the following data types to produce estimates:

  • Demographic data: Population split by segments
  • Macroeconomic indicators: GDP, PPP, Per Capita Income, etc.
  • Industry indicators: Expenditure, technology stage and infrastructure, sector growth and facilities
  • Data is then cross-checked by an expert panel.

Free Analysis

Active pharmaceutical ingredient (API) is used in the manufacturing of a pharmaceutical drug as a biologically active compound. API is an organic compound which has unique chemical structure and stereochemistry. Any medication is made up of two portions. The first is the active pharmaceutical ingredients, which is the essential element of the drug. The second is known as an excipient which is an inner part of the drug. The active pharmaceutical ingredient is the chemically active substance, which is intended to deliver the desirable impact in the body.

The market for API is driven by a number of factors, such as increasing prevalence of chronic diseases, technological advancements in the API manufacturing, and growing incidences of age-related diseases. Furthermore, patent expiration of major drugs that increased generic drug sales, government initiatives flourishing the market growth. However, stringent regulatory requirement and decline in global economics may curb the worldwide active pharmaceutical ingredient market.

Global Active Pharmaceutical Ingredients market

The global active pharmaceutical ingredient market is broadly segmented based on API synthesis, type of manufacturing, type of API, and type of drug, application and by region. On the basis of API, synthesis market is segmented into biotech API, synthetic chemical API, and HPAPI (Highly Potent Active Pharmaceutical Ingredient). The biotech API is the leading segment and acquired a significant share in overall API market in 2015. On the basis of the type of manufacturing, the market is segmented into API contract manufacturing and in-house API manufacturing. The contract manufacturing emerged as major segment due to lower cost and higher quality of production of the API. Type segment of API includes synthetic API and biological API.

By type of drug, the market is segmented into branded drugs, generic drugs, and OTC (Over the Counter) drugs.  The generic prescription drugs segment is expected to witness the highest growth in the upcoming years due to their low cost compared to branded drugs. Cardiology, oncology, anti-inflammatory, gastrointestinal and others are the key therapeutic application segmentation of API market. According to World Health Organization (WHO), cancer was one of the major causes of mortality across the globe. Thus, the oncology segment is expected to be the fastest-growing segment of the global API market.

North America dominated the global API market in 2015 followed by Europe due to development in the pharmaceutical industry, and technological advancement in API. Asia-Pacific is considered as a fastest growing market for active pharmaceutical ingredient due to increasing new drug application in this region.

Major players in active pharmaceutical ingredient market are Sun Pharmaceuticals Industries Limited, Novartis International AG, BASF SE, Pfizer, Inc., Aurobindo, Albemarle Corporation, and Boehringer Ingelheim among others.

Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Accept

We have secured system to process your transaction.


We Are On Social